ArticleInternational journal of hematology2014

Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.

Takashi Kumagai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.